We can't find the internet
Attempting to reconnect
18146.1 PFLS-LS
18146.1 PFLS-LS
Zusammenfassung
Development of novel antibiotics with additional host-protective anti-inflammatory properties against life threatening infections caused by MDR Gram-negative ESKAPE pathogens
Weitere Texte
Abstract
In earlier work, POL7080 was discovered; an antibiotic targeting Pseudomonas aeruginosa with a novel mode-of-action, which is currently in Phase II clinical trials. In this project, a new series of peptidomimetics with a broader spectrum of antibacterial activity against multi-drug resistant (MDR) and colistin-resistant Gram-negative ESKAPE pathogens will be studied, possessing also potential host-protective anti-inflammatory activity.
Beteiligte
Daniel Obrecht
Wirtschaftspartner
daniel.obrecht@polyphor.com
Spexis AG CHE-108.535.251 Daniel Obrecht Hegenmattweg 125 4123 Allschwil BL CH
John A. Robinson
Kontaktperson
robinson@oci.uzh.ch
Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstrasse 190 8057 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2018-12-31
- Bewilligte Gesamtkosten
- CHF 993600.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%